PALISADE CAPITAL MANAGEMENT, LP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 16 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,483,300
-44.9%
2,614,000
-44.9%
0.07%
-42.5%
Q2 2023$4,503,000
+3.0%
4,740,0000.0%0.12%
+1.7%
Q1 2023$4,369,806
+1.4%
4,740,0000.0%0.12%
+1.7%
Q4 2022$4,307,373
-1.2%
4,740,0000.0%0.12%
-6.5%
Q3 2022$4,361,000
+4.6%
4,740,0000.0%0.12%
+9.7%
Q2 2022$4,168,000
-34.1%
4,740,000
-32.6%
0.11%
-22.1%
Q1 2022$6,320,000
+89.7%
7,032,000
+90.1%
0.14%
+116.4%
Q4 2021$3,332,0003,700,0000.07%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 36,587,000$34,026,0003.65%
DeepCurrents Investment Group LLC 77,144,000$71,504,0002.14%
STEELHEAD PARTNERS LLC 28,000,000$26,028,0001.72%
Context Capital Management, LLC 13,000$12,147,0001.12%
CAMDEN ASSET MANAGEMENT L P /CA 26,324,000$24,465,0001.02%
Penn Mutual Asset Management, LLC 856$790,0000.99%
TENOR CAPITAL MANAGEMENT Co., L.P. 41,774,000$38,742,0000.84%
PFM Health Sciences, LP 23,000,000$21,372,0000.67%
AQR Arbitrage LLC 19,050,000$17,800,0000.50%
ADVENT CAPITAL MANAGEMENT /DE/ 19,910,000$18,377,0000.36%
View complete list of IONIS PHARMACEUTICALS INC shareholders